Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-07-07 00:00:00 ET · period of report 2021-07-02 · accession 0001708138-21-000036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-07 | 2021-07-02 | REGN | LAROSA JOSEPH J | EVP GC, Secret | F - Tax | $582.20 | -6,602 | 16.6K | -28% | -$3.84M |
| D | 2021-07-07 | 2021-07-02 | REGN | LAROSA JOSEPH J | EVP GC, Secret | M - OptEx | $179.13 | +10.0K | 23.2K | +76% | +$1.79M |
| D | 2021-07-07 | 2021-07-06 | REGN | LAROSA JOSEPH J | EVP GC, Secret | S - Sale+OE | $580.00 | -3,398 | 13.2K | -20% | -$1.97M |
| D | 2021-07-07 | 2021-07-02 | REGN | LAROSA JOSEPH J | EVP GC, Secret | M - OptEx | $0.00 | -10.0K | 40.0K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-02 | F | D | 6,602 | $582.20 | 16,580 | D | — | — | |
| 2 | Common | Common Stock | 2021-07-02 | M | A | 10,000 | $179.13 | 23,182 | D | — | — | |
| 3 | Common | Common Stock | 2021-07-06 | S | D | 3,398 | $580.00 | 13,182 | D | — | — | |
| 4 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-07-02 | M | D | 10,000 | $0.00 | 40,000 | D | $179.13 · — to 2022-12-14 | 10,000 Common Stock | (F2) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |